Citation: Md. Rawlins et Am. Breckenridge, CLINICAL BENEFIT MUST NOT BE CONFUSED WITH COST-BENEFIT, BMJ. British medical journal, 316(7127), 1998, pp. 310-311
Authors:
JEFFERYS DB
LEAKEY D
LEWIS JA
PAYNE S
RAWLINS MD
Citation: Db. Jefferys et al., NEW ACTIVE SUBSTANCES AUTHORIZED IN THE UNITED-KINGDOM BETWEEN 1972 AND 1994, British journal of clinical pharmacology, 45(2), 1998, pp. 151-156
Citation: Pg. Aithal et al., THE ACCURACY AND CONSEQUENCES OF HEPATIC ADVERSE DRUG REACTION REPORTING IN THE UNITED-KINGDOM, Hepatology, 28(4), 1998, pp. 569-569
Citation: Md. Rawlins, VENOUS THROMBOEMBOLISM AND THE PILL - LEARNING FROM THE PAST - A RESPONSE FROM THE COMMITTEE ON SAFETY OF MEDICINES, Human reproduction (Oxford. Print), 13(7), 1998, pp. 1781-1781
Citation: Md. Rawlins, COMMENTARY - SHOULD IDIOSYNCRASY BE DEFINED AS EQUIVALENT TO TYPE-B ADVERSE DRUG-REACTIONS, Pharmacoepidemiology and drug safety, 6(4), 1997, pp. 291-291
Authors:
LEE A
BATEMAN DN
EDWARDS C
SMITH JM
RAWLINS MD
Citation: A. Lee et al., REPORTING OF ADVERSE DRUG-REACTIONS BY HOSPITAL PHARMACISTS - PILOT SCHEME, BMJ. British medical journal, 315(7107), 1997, pp. 519-519
Authors:
BELTON KJ
GRAM LF
ROYER RJ
FEELY J
MCGETTIGAN P
VELO GP
CONFORTI A
LEONE R
STRICKER BHC
TEIXEIRA F
LAPORTE JP
CAPELLA D
BEERMANN B
LEWIS SC
PAYNE S
RAWLINS MD
WOOD SM
Citation: Kj. Belton et al., ATTITUDE SURVEY OF ADVERSE DRUG-REACTION REPORTING BY HEALTH-CARE PROFESSIONALS ACROSS THE EUROPEAN-UNION, European Journal of Clinical Pharmacology, 52(6), 1997, pp. 423-427
Citation: Uj. Moore et al., THE ANALGESIC EFFICACY OF NALOXONE IN THE CONTROL OF POSTOPERATIVE DENTAL PAIN, Journal of dental research, 76(5), 1997, pp. 1024-1024
Citation: Md. Rawlins, THE CLINICAL PHARMACOLOGIST IN DRUG REGULATION - A EUROPEAN PERSPECTIVE, British journal of clinical pharmacology, 42(1), 1996, pp. 59-61
Authors:
BELTON KJ
LEWIS SC
PAYNE S
RAWLINS MD
WOOD SM
Citation: Kj. Belton et al., ATTITUDINAL SURVEY OF ADVERSE DRUG REACTION REPORTING BY MEDICAL PRACTITIONERS IN THE UNITED-KINGDOM, British journal of clinical pharmacology, 39(3), 1995, pp. 223-226
Authors:
BROWN ASJM
FIATARONE JR
WOOD P
BENNETT MK
KELLY PJ
RAWLINS MD
DAY CP
JAMES OFW
Citation: Asjm. Brown et al., THE EFFECT OF GASTRITIS ON HUMAN GASTRIC ALCOHOL-DEHYDROGENASE ACTIVITY AND ETHANOL-METABOLISM, Alimentary pharmacology & therapeutics, 9(1), 1995, pp. 57-61
Citation: Md. Rawlins, PHARMACOVIGILANCE - PARADISE-LOST, REGAINED OR POSTPONED (VOL 29, PG 46, 1995), Journal of the Royal College of Physicians of London, 29(2), 1995, pp. 118-118
Citation: Md. Rawlins, PHARMACOVIGILANCE - PARADISE-LOST, REGAINED OR POSTPONED - THE WILLIAM WITHERING LECTURE 1994, Journal of the Royal College of Physicians of London, 29(1), 1995, pp. 41-49
Authors:
WALLER PC
WOOD SM
BRECKENRIDGE AM
RAWLINS MD
Citation: Pc. Waller et al., WHY THE SAFETY ASSESSMENT OF MARKETED MEDICINES (SAMM) GUIDELINES ARENEEDED, British journal of clinical pharmacology, 38(2), 1994, pp. 93-93
Citation: Uj. Moore et al., THE EFFICACY OF LOCALLY APPLIED MORPHINE IN POSTOPERATIVE PAIN AFTER BILATERAL 3RD MOLAR SURGERY, British journal of clinical pharmacology, 37(3), 1994, pp. 227-230
Citation: Ib. Turner et al., FLUMECINOL FOR THE TREATMENT OF PRURITUS ASSOCIATED WITH PRIMARY BILIARY-CIRRHOSIS, Alimentary pharmacology & therapeutics, 8(3), 1994, pp. 337-342
Authors:
LANGMAN MJS
WEIL J
WAINWRIGHT P
LAWSON DH
RAWLINS MD
LOGAN RFA
MURPHY M
VESSEY MP
COLINJONES DG
Citation: Mjs. Langman et al., RISKS OF BLEEDING PEPTIC-ULCER ASSOCIATED WITH INDIVIDUAL NONSTEROIDAL ANTIINFLAMMATORY DRUGS, Lancet, 343(8905), 1994, pp. 1075-1078
Citation: Md. Rawlins et Db. Jefferys, UNITED-KINGDOM PRODUCT LICENSE APPLICATIONS INVOLVING NEW ACTIVE SUBSTANCES, 1987-1989 - THEIR FATE AFTER APPEALS, British journal of clinical pharmacology, 35(6), 1993, pp. 599-602
Citation: Ha. Wynne et Md. Rawlins, ARE SYSTEMIC LEVELS OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS RELEVANT TO ACUTE UPPER GASTROINTESTINAL HEMORRHAGE, European Journal of Clinical Pharmacology, 44(4), 1993, pp. 309-313